Propanc Biopharma Explains How PRP Could Impact Pancreatic Cancer

The Science, Clinical Promise, & Market OutlookMELBOURNE, Australia, Jan. 15, 2026 (GLOBE NEWSWIRE) -- Propanc Biopharma, Inc. (Nasdaq: PPCB) (“Propanc” or the “Company”), a biopharmaceutical company ...
WRIC

APEX Biologix Enters Exclusive U.S. Distribution Agreement with Bioventus LLC for XCELL PRP® System

CLEARWATER, FL, UNITED STATES, May 20, 2025 / EINPresswire.com / -- APEX Biologix, a leading provider of advanced biologic interventions and regenerative medicine solutions, is pleased to announce an ...

European Court Enforces EU MDR Rules on PRP Devices, Sending a Global Compliance Signal

Düsseldorf District Court issues preliminary injunction against Beijing Hanbaihan Medical Devices Co., Ltd. regarding ...
Medscape

Trials Aim to Show Benefit of Orthobiologic for Knee OA

Orthobiologics are a rapidly advancing area in orthopedics and regenerative medicine. Derived from biologic substances, these treatments are used to help relieve pain associated with orthopedic ...
Seeking Alpha

ADIA Nutrition Inc. Requests SIC Code Update to 2836 (Biological Products) with SEC and OTC Markets

Adia Labs LLC sells FDA-registered 361 HCT/Ps (AdiaVita, AdiaLink) sold nationwide to physicians. Adia Med clinics, owned by ADIA, perform specialty regenerative treatments including stem cell therapy ...